Kaviya Devaraja

Ms. Kaviya Devaraja

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
MSMarlie Smith
Marlie Smith
SKSimone Kurup
Simone Kurup
KDKaviya Devaraja
Kaviya Devaraja
SSShaayini Shanawaz
Shaayini Shanawaz
LRLorrie Reynolds
Lorrie Reynolds
AKAlisha Kassam
Alisha Kassam
Adolescents and young adults (AYAs) with cancer, representing those between 15 and 39 years of age, face distinctive challenges balancing their life stage with the physical, emotional, and social impacts of a cancer diagnosis. These challenges include fertility concerns, disruptions to educational and occupational pursuits, issues related to body image and sexual health, and the need for age-appropriate psychosocial support within their communities. The Princess Margaret Cancer Centre (PM), a quaternary care center, established a specialized AYA program in 2014, offering holistic and developmentally tailored psychosocial support and currently, efforts are underway to expand this to other regions in the province to address the need for equitable access. The establishment process involves securing funding, conducting an environmental scan, identifying service gaps, developing clinical pathways, and implementing AYA supportive care. An accessible AYA program should also consider social determinants of health, social location, intersectionality, and an interdisciplinary health approach in understanding health inequities in AYA oncology care. This paper describes the processes implemented and challenges faced in creating a community-based AYA program beyond major resource-rich cities and efforts to address intersectionality.

8 April 2025 in Cancer Medicine
Verified
Journal Article
Open access
KDKaviya Devaraja
Kaviya Devaraja
MDMaureen Daniels
Maureen Daniels
DTDerek S. Tsang
Derek S. Tsang
KEKim Edelstein
Kim Edelstein
JBJulie Bennett
Julie Bennett
JAJonathan Avery
Jonathan Avery
Background: Adolescents and young adults (AYA, 18–39) with high‐grade glioma (HGG) face unique challenges at a life stage focused on autonomy, careers, relationships, and family planning.Aim: This study explores their experiences to inform life‐stage appropriate support and resources.Methods: In this mixed‐methods study, we surveyed AYA HGG patients at Princess Margaret Cancer Centre (PM) to assess symptom experiences and care satisfaction. Interviews further explored their illness experiences and needs. Descriptive statistics summarized survey data, and thematic analysis guided by Braun and Clarke's framework identified key interview themes. Triangulation compared survey and interview results for a comprehensive understanding.Results: Seventeen participants (7 men, 10 women; mean age 30.57) completed surveys and interviews. Triangulation revealed typical AYA challenges, such as delays in education, careers, and relationships, along with HGG‐specific issues. Three main themes emerged: (1) managing cognitive and treatment‐related impacts on life goals, (2) addressing physical and cognitive impairments affecting relationships, and (3) navigating identity loss and independence due to neurological symptoms.Conclusions: These findings highlight the need for tailored interventions and educational support integrated into AYA HGG care pathways.

12 July 2023 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
KDKaviya Devaraja
Kaviya Devaraja
SMSheila Mansouri
Sheila Mansouri
OSOlivia Singh
Olivia Singh
HAHafsah Ali
Hafsah Ali
VPVikas Patil
Vikas Patil
GZGelareh Zadeh
Gelareh Zadeh
Glioblastoma (GBM) is a fatal brain cancer in adults with ineffective treatment methods. Cell adhesion molecules (CAMs) are proteins that are expressed on the surface of cells and enable them to interact with one another and the surrounding microenvironment. Intracellular adhesion molecule 1 (ICAM-1) is a cell adhesion molecule expressed by various cell types. Preliminary data showed that ICAM-1 is associated with poorer overall and progression free survival in patients and ICAM-1 expression levels increase in recurrent tumors. TAMs enhance GBM tumor growth. The aim of this study was to determine if ICAM-1 expression on TAMs contributes to GBM tumorigenesis, specifically within the hypoxic tumor microenvironment. We hypothesized that ICAM1 facilitates TAM migration, proliferation, cell adhesion and phagocytosis, thus enhancing tumor growth. We found that upon incubation of human and mouse primary macrophages in hypoxia, ICAM-1 expression levels increased and were further exasperated upon culturing with tumor cell-conditioned medium. The migration, cell adhesion and phagocytosis of ICAM-1 deficient macrophages was lower than wild type macrophages, and effects were further exasperated upon culturing with tumor conditioned media and incubation in hypoxia. Intracranial injection of tumor cells into ICAM-1 deficient and wild type mice revealed that ICAM1 deficient mice survived longer with lower overall tumor volume than wild type mice, with survival and volume differences being rescued upon ICAM1 bone marrow reconstitution. In conclusion, the expression of ICAM1 in TAMs likely promotes GBM tumorigenesis and hypoxia further enhances the expression of ICAM-1 in macrophages which is associated with more aggressive GBM.

19 July 2024 in Neuro-Oncology Practice
Verified
Journal Article
Closed access
KDKaviya Devaraja
Kaviya Devaraja
JAJonathan Avery
Jonathan Avery
YIYajur Iyengar
Yajur Iyengar
YZYunyi Zhang
Yunyi Zhang
SCSeth A Climans
Seth A Climans
Background: Primary central nervous system (CNS) tumors significantly affect individuals globally, with patients in Ontario, Canada, often bearing financial burdens for treatments such as oral chemotherapy due to insufficient coverage, resulting in complex insurance processes or out-of-pocket payments. However, limited understanding exists regarding other direct and indirect financial implications of their diagnosis. This study examines the financial strains, unmet needs, and overarching challenges encountered by Ontario’s brain tumor patients, utilizing GoFundMe posts as a unique data source to explore additional financial costs linked to CNS tumor diagnoses in the region. Methods: A qualitative descriptive design employing thematic analysis analyzed GoFundMe posts supporting CNS tumor patients in Ontario from 2014 to 2021. A search strategy targeted posts featuring primary CNS tumor keywords, with NVivo 10 software facilitating post organization and coding. Results: Focused on Ontario, the study yielded a final dataset of 154 posts from an initial pool of 9025, revealing further financial strain due to income loss among patients and caregivers. Posts highlighted various concerns: (1) navigating the complexities of accessing support services, (2) worries about family’s long-term financial and overall well-being, (3) insufficient public awareness about the financial and emotional burden on those affected, and (4) seeking emotional support, hope, and encouragement from the community. Conclusions: These GoFundMe posts highlight a connection between financial burden, emotional distress, and the need for improved access to financial and emotional support services. The results emphasize distinct financial challenges faced by CNS tumor patients within Ontario’s healthcare system.

22 February 2026 in Gynecologic Oncology Reports
Verified
Journal Article
Open access
KDKaviya Devaraja
Kaviya Devaraja
ASAnjali Sachdeva
Anjali Sachdeva
KGKarina Gandhi
Karina Gandhi
AGAbha A. Gupta
Abha A. Gupta
JCJennifer Croke
Jennifer Croke
Pelvic radiotherapy (RT) is an effective treatment for pelvic malignancies but often leads to sexual and reproductive health (SRH) challenges, particularly among adolescent and young adult (AYA) patients assigned female at birth (AFAB). Despite known toxicities, no study has systematically explored the SRH experiences, challenges, and unmet care needs of this population post-RT. This study aimed to assess SRH impacts and identify gaps in care among AYA AFAB cancer survivors following pelvic RT. We conducted a simultaneous mixed-methods study at a tertiary cancer center. AYA AFAB patients aged 18–39 who completed pelvic RT between 2018 and 2023 completed a 23-item survey assessing SRH experiences and care satisfaction; a subset participated in in-depth interviews. Quantitative data were analyzed descriptively, and qualitative data were examined using thematic analysis. Triangulation enabled a comprehensive understanding of patient experiences. Fifty-two participants completed the survey (median age 33), and 15 completed interviews. Most reported sexual dysfunction (90%), intimacy disruption (90%), and fertility-related distress (87%). Three themes emerged: (1) RT-induced sexual dysfunction negatively affected relationships and intimacy, (2) fertility and reproductive disruptions were compounded by inadequate education and support, and (3) chronic pelvic discomfort and body image changes caused emotional and psychosocial distress. Participants emphasized limited provider communication, scarce RT-specific SRH resources, and lack of post-treatment supports. This first study characterizing RT-specific SRH disruptions among AYA AFAB survivors underscores the urgent need for age-appropriate survivorship care integrating SRH education, counseling, and partner-inclusive supports.

12 January 2026 in Neuro-Oncology Advances
Verified
Journal Article
Open access
SGShreya Gandhi
Shreya Gandhi
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
MBManuel M Bettencourt
Manuel M Bettencourt
OSOlivia S Singh
Olivia S Singh
KDKaviya Devaraja
Kaviya Devaraja
SMSheila Mansouri
Sheila Mansouri
Background: Glioblastoma (GB) exhibits marked tumor microenvironmental heterogeneity, contributing to both therapy resistance and poor survival outcomes. Intercellular adhesion molecule 1 (ICAM1) is an inflammation-associated adhesion molecule implicated in immune-stromal interactions, but its clinical and biological significance in GB remains incompletely defined. Methods: We performed ICAM1 immunohistochemistry, bulk RNA sequencing, DNA methylation analysis, single-nucleus RNA sequencing, and preoperative MRI-derived morphologic feature analysis across multi-institutional cohorts of treatment-naïve IDH-wildtype GB. Results: High ICAM1 expression at both transcript and protein levels is associated with shorter overall survival, particularly within the mesenchymal transcriptional subtype. ICAM1 expression is inversely associated with promoter methylation. Single-nucleus RNA-sequencing analysis shows that ICAM1-high tumors are enriched for mesenchymal, hypoxia, stress-associated, and immunosuppressive myeloid programs, suggesting that ICAM1 reflects a multicompartment inflammatory tumor ecosystem. ICAM1 expression, tumor surface irregularity, and patient age are independently prognostic and minimally correlated, capturing complementary clinical, imaging, and molecular features of GB biology. When combined, our Clinical-Imaging-Molecular (CIM) framework refines outcome prediction across independent GB cohorts using routinely available clinical data, conventional imaging, and standard immunohistochemistry. Conclusions: ICAM1 characterizes an immune-remodeled, stress-adapted GB ecosystem associated with poor clinical outcomes. Integrating patient age, surface irregularity, and ICAM1 expression yields a scalable and clinically accessible prognostic framework for GB, supporting tailored outcome prediction, particularly in low- and middle-resource settings without routine access to advanced molecular profiling.